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Abstract
Background: Gait disturbances are typical of persons with idiopathic normal pressure hydrocephalus (iNPH)
without signs distinctive from other neurodegenerative and vascular conditions. Cerebrospinal fluid tap-test (CSF-TT) is
expected to improve the motor performance of iNPH patients and is a prognostic indicator in their surgical management.
This observational prospective study aims to determine which spatio-temporal gait parameter(s), measured during
instrumented motor tests, and clinical scale(s) may provide a relevant contribution in the evaluation of motor
performance pre vs. post CSF-TT on iNPH patients with and without important vascular encephalopathy.
Methods: Seventy-six patients (20 with an associated vascular encephalopathy) were assessed before, and 24 and 72 h
after the CSF-TT by a timed up and go test (TUG) and an 18m walking test (18mW) instrumented using inertial sensors.
Tinetti Gait, Tinetti Balance, Gait Status Scale, and Grading Scale were fulfilled before and 72 h after the CSF-TT. Stride
length, cadence and total time were selected as the outcome measures. Statistical models with mixed effects were
implemented to determine the relevant contribution to response variables of each quantitative gait parameter and
clinical scales.
Results and conclusion: From baseline to 72 h post CSF-TT patients improved significantly by increasing cadence in 18
mW and TUG (on average of 1.7 and 2.4 strides/min respectively) and stride length in 18mW (on average of 3.1 cm). A
significant reduction of gait apraxia was reflected by modifications in double support duration and in coordination index.
Tinetti Gait, Tinetti Balance and Gait Status Scale were able to explain part of the variability of response variables not
covered by instrumental data, especially in TUG. Grading Scale revealed the highest affinity with TUG total time and
cadence when considering clinical scales alone.
Patients with iNPH and an associated vascular encephalopathy showed worst performances compared to pure iNPH but
without statistical significance. Gait improvement following CSF-TT was comparable in the two groups. Overall these
results suggest that, in order to augment CSF-TT accuracy, is key to assess the gait pattern by analyzing the main spatio-
temporal parameters and set post evaluation at 72 h.
Trial registration: Approved by ethics committee: CE 14131 23/02/2015.
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Background
Idiopathic normal pressure hydrocephalus (iNPH) is a
syndrome characterized by chronic ventricular dilation,
normal cerebrospinal fluid (CSF) pressure and the triad
of symptoms: gait apraxia, urinary incontinence, and
cognitive deficits [1]. Treating iNPH with the insertion
of a ventricular peritoneal shunt allows draining exces-
sive cerebrospinal fluid, [2] which in turn can lead up to
a complete recovery [2, 3]. A recent systematic review
reported symptoms improvement following shunt inser-
tion in 71% of the three thousand patients analyzed in
64 published studies [3].
Still, the diagnosis of iNPH is complicated due to the
considerable variability in its clinical presentation and
course. Following current consensus guidelines, iNPH
should be diagnosed from clinical history, physical
examination, and brain imaging [2, 4, 5]. Practically, it is
usually identified by the exclusion of other conditions
once specific treatments for Parkinsonism or musculo-
skeletal diseases are ineffective. Nonetheless, a delayed
diagnosis causes a disease progression to a point where
treatment may be no longer effective [6].
The gait of iNPH patients is usually described as
bradykinetic, shuffling, unstable on turning and with
reduced walking speed [4]. Besides, it is typically mag-
netic, with an increased double support duration wit-
nessing a difficulty in limb rising and step initiation
[7]. Overall gait is apraxic, and this is usually the most
disabling symptom and first sign onset, whereas cogni-
tive impairment and urinary incontinence might
appear in a later stage [4]. Gait apraxia is a common
symptom also in patients affected by vascular enceph-
alopathy [8]. Thus, iNPH and vascular encephalopathy
conditions are often confused with each other. Moreover,
vascular encephalopathy might result as a comorbidity of
iNPH, potentially limiting the effectiveness of surgical
treatment.
Supplementary prognostic tests, e.g., CSF tap-test
(CSF-TT), have been used to attain a higher specificity
and sensitivity for diagnosing iNPH and for predicting
shunt response [2, 9]. The rationale is that temporary
symptoms improvement from CSF drainage is prognos-
tic for following shunt insertion. In a recent review study
from Mihalj et al., the accuracy of CSF-TT in screening
patients for shunting is 62%, but its negative predictive
value is merely 37% [10]. This latter unsatisfactory result
can be potentially ascribed to the use of ineffective tools
in the analysis of post-CSF-TT improvements. In fact,
the measure of gait changes is frequently based on quali-
tative, examiner-based evaluations rather than quantita-
tive analyses, possibly leading to a misinterpretation of
the findings [11]. Gait is commonly evaluated with the
10-m walking test (10 mW) having the test duration as a
single outcome, or by clinical scales such as the iNPH
Grading Scale [12]. This latter, in particular, is a clinician-
rated scale aimed at separately assessing the severity of
each of the three main symptoms [13]. As well, the Gait
Status Scale was explicitly designed for analyzing gait dis-
turbances of iNPH patients on the base of simple clinical
observations [13].
Instrumented gait analysis may conversely be a crucial
tool to augment CSF-TT accuracy allowing to object-
ively assess the improvements through a precise measure
of the gait pattern [7]. Among different systems available
for gait analysis, inertial measurement units (IMUs) are
nowadays opening new perspectives in instrumenting
motor tests [14]. The latest generation of IMUs are
indeed wireless, small, lightweight, cost-effective and
operating in real-time, therefore allowing the plug-
and-play execution of gait analysis tests in the times
of clinical routine [15]. Besides, the use of apps for
mobile devices allows us to run the tests in any
environment and to have detailed reports right after
their executions [15, 16].
Just a few studies investigated the effects of CSF-TT
through an instrumented gait analysis. Among these,
Stolze et al. in a study involving 10 iNPH patients,
reported gait speed and stride length as the most
responsive parameters in a pre- vs. 24 h post-CSF-TT
comparison, whereas cadence and balance remained
unaffected [17]. More recently, Panciani et al. compared
gait performances on 52 iNPH patients pre vs. few hours
post-CSF-TT finding improvements in gait speed, stride
length and double support duration [18]. Another study
compared performances on a timed-up and go test
(TUG) pre vs. 24 h post-CSF-TT revealing significant
improvements in the sit-to-stand transition, walking
time, and the number of steps employed to turn [19].
Allali et al. found a significant improvement of gait
speed in single and dual tasking of 10 mW in a pre vs.
24 h post-CSF-TT [20]. In a study involving 74 patients,
significant differences pre and 2-4 h post-CSF-TT were
revealed for the Performance Oriented Mobility Assess-
ment (Tinetti, [21]) and the Berg Balance Scale. Partially
in contrast with these findings, TUG and 10 mW
revealed improvements just in those patients assessed as
eligible for shunt neurosurgery [22].
Gait changes after CSF-TT is a transient phenomenon,
but literature does not offer an agreement about when it is
the time point where the maximal modification can be
expected [10]. Several studies analyzed the motor perfor-
mances of patients not after a predefined amount of time,
but on different days [23]. Other studies provided evidence
of improvement within the first 24 h [7, 11, 18, 22]. In par-
ticular, Virhammar et al. reported improvements in gait
speed of 10mW since 1 h to 24 h post-CSF-TT [12]. On
the contrary, many other studies recommend examining
patients performances since the second day after the CSF-
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TT [17, 19, 20, 24]. Recently, Schniepp et al. examined 24
iNPH patients employing sequential recordings of gait
velocity from 1 h to 72 h [25]. The maximal increase
was observed in single-tasking after 24 h to 48 h,
whereas in dual-tasking after 48 h to 72 h. The low
negative predictive value in screening patients for
shunting of CSF-TT (37%) might also depend on post
evaluations not acquired on the appropriate time
point [25].
The aim of this paper was threefold: i) to determine
the contribution of gait analysis data obtained using
IMUs and clinical scales on assessing pre vs. post-CSF-
TT modifications in motor performance, ii) to determine
the influence of the association between iNPH and
vascular encephalopathy on CSF-TT outcomes, and iii)
to evaluate whether CSF-TT effect on gait performance
is more relevant after 24 or 72 h.
Methods
Participants
This observational prospective study was conducted
between May 2015 to May 2018 in the Institute of
Neurological Sciences (IRCCS) of Bologna, a national
referral neurological and neurosurgical inpatient facility.
Population eligible for inclusion in the study consisted
of subjects: i) aged over 50 years old, ii) presenting at
least one of the symptoms of the iNPH clinical triad [4],
and iii) able to give verbal and written informed consent.
Exclusion criteria were: i) the presence of severe psychi-
atric disease or physical illness, and ii) addiction to
drugs. Patients eligible were admitted for investigation of
iNPH by referral from neurologists, geriatricians, neuro-
surgeons and general practitioners and scheduled for a
3-Tesla-MRI brain scan. Patients with a clinical history
possibly causing ventricular dilation, such as subarach-
noid hemorrhage, meningitis, head injury, congenital
hydrocephalus or aqueductal stenosis, were excluded.
The diagnosis was assigned after reviewing: i) clinical
data, ii) neuroimages, iii) neuropsychological informa-
tion, and iv) blood and CSF composition tests during a
consensus case conference comprising neurologists, neu-
rosurgeons, neuropsychologists, neuroradiologists, phys-
iatrists and nurses of the Institute of Neurological
Sciences (IRCCS) of Bologna [26].
White matter changes were quantified on neuroimages
with the Age-Related White Matters Changes (ARWMC)
scale [27]. In this scale, the frontal, the parieto-occipital,
the temporal, the infratentorial and the basal ganglia areas
of right and left hemisphere are individually rated with a
score ranging from 0 to 3 according to the number and
degree of confluence of lesions. iNPH patients were classi-
fied in pure hydrocephalus (p-iNPH) or hydrocephalus
with important vascular encephalopathy (v-iNPH) in case
the overall score of ARWMC was respectively below or
above 10. Considering the absence in the literature of a
validated cut-off value, the one here proposed was estab-
lished based on the expert opinion of the neuroradiologist.
This study was approved by the local ethics committee
of the health service of Bologna, reference CE 14131 23/
02/2015, and was conducted in agreement with princi-
ples of good clinical practice. All participants gave their
written consent to participation according to the declar-
ation of Helsinki.
Protocol
The CSF-TT consisted in the removal of 30–40ml of
CSF using a 20-gauge spinal needle in lateral supine
position.
Gait was assessed by TUG being the standard motor
test in studies involving iNPH patients to assess balance
and mobility [28], and by 10mW extended to the dis-
tance of 18 m (18 mW), as proposed by Kahlon et al.
[29]. During TUG patients raised from a chair with arm-
rests, walked 3 m forward, turned 180° around a traffic
cone, walked 3 m backward and sat back on the same
chair. During 18 mW patients were instructed to walk
on a straight line at a self-selected pace along a large
and empty corridor 30 m long. Both tests were repeated
three times in order to filter out the effect due to habitu-
ation or lack of attention. Gait was quantitatively
assessed by TUG pre- (baseline), 24 h- (T24 h) and 72 h
(T72 h) post-CSF-TT and by 18mW at baseline and
T24 h. In order to better infer the performance modifi-
cation along the three time points, on the firsts 15 pa-
tients (10 p-iNPH and 5 v-iNPH) the 18 mW was also
acquired at T72 h.
The TUG and 18 mW were instrumented using
mGAIT (mHealth Technologies, Italy). In particular,
three inertial sensors equipped with a triaxial accelerom-
eter (full scale set at ±8 g) and a triaxial gyroscope (full
scale set at ±1000°/s) and with a sampling rate of 100 Hz
were wore two on the shoes and one on the lower trunk
[30]. The sensors connected via Bluetooth to an Android
smartphone using an app which functioned as a portable
processing platform. The app implemented ad-hoc algo-
rithms to detect the gait cycle events and an extended
Kalman filter with zero velocity updates to determine
the spatial gait parameters using the same framework re-
ported in Ferrari et al. [15]. Threshold values and condi-
tional expressions of the algorithms were tuned based
on data coming from pathological gait patterns of pa-
tients with major neurological conditions.
Gait data were processed in real-time. At the end of
tests the app provided the following parameters for ana-
lysis: i) test total time, ii) gait speed, iii) stride length, iv)
cadence, v) phases of the gait cycle (duration of single
and double support expressed as percentage of gait
cycle, stance and swing), vi) phase coordination index
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(PCI) as a measure of gait coordination [31]. The trunk
acceleration signals recorded during the TUG were
processed, using Matlab 2017b (Mathworks Inc., USA),
similarly to Palmerini et al. [32]. In particular, the trunk
inclination was obtained through an inverse pendulum
model as the arcsin of the vertical component of the ac-
celeration normalized to gravity and zeroed to the initial
sitting position. The following parameters were deter-
mined: vii) sit-to-stand duration, viii) number of steps to
turn, ix) stand-to-sit duration, and x) time taken to walk.
At baseline and T72 h the following clinical scales
were fulfilled: 1) Grading Scale, 2) Tinetti, 3) Gait Status
Scale. For Grading Scale and Gait Status Scale, higher
scores indicate more impaired motor abilities. Tinetti
consists of: i) a balance section (Tinetti Balance), asses-
sing 9 items scored out of 16 points, ii) a gait section
(Tinetti Gait), assessing 8 items scored out of 12 points,
and iii) a combined score (Tinetti) of 28 points as a re-
sult of the sum of the previous two. Higher scores mean
less impaired motor abilities.
Statistical analysis
Following what observed by Hollman et al. [33], in order
to carefully evaluate all the complimentary aspects of
gait that contribute to a modification in motor perform-
ance as a result of the CSF-TT, three parameters were
selected as main responsive variables: i) cadence, ii)
stride length, and iii) test total time.
With the goal of reducing measurement error, aver-
aging of repeated measurements is common practice
when analyzing outcomes in clinical research. However
this procedure also removes useful information [34].
Furthermore, without properly considering test repeti-
tions at the same time point as repeated within-subject
measurements, efficiency and statistical power worsen.
As also recently recommended by an editorial of Gait
and Posture by Prescott RJ [35], the use of a linear
model with mixed effects on non-averaged data can con-
versely properly account for correlation between re-
peated measurements, keep the narrowest confidence
intervals for clinical parameters, hold the greatest statis-
tical efficiency [36], and flexibly model time effects [37].
In this study, linear models with mixed effects were
implemented using backward elimination for each of the
three main responsive variables using R (https://www.r-
project.org/). Backward elimination is a stepwise proced-
ure that consists in including all the candidate variables
to fit the statistical model and that, at each step, deletes
the regressor (if any) whose loss gives most statistically
insignificant deterioration to the fit of the reduced
model, until no further variables can be deleted without
a statistically significant loss of fit. Eq. 1 reports the
complete model from which started the analysis of
spatio-temporal gait parameters as regressors to the
three response variables:
Equation 1: Complete linear model with mixed effects
used to determine effect of CSF-TT on modification of
motor performance during instrumented TUG and 18
mW
PerformanceMeasureirt ¼ β0 þ β1Ti þ agei þ BMIi
þ diagnosisi
þ doubleSupportDurationirt
þ PCIirt þ turningStepsirt
þ sitToStandirt
þ standToSitirt
þ walkTimeirt þ b0it
þ εirt ≡ μit þ b0it þ εirt
where PerformanceMeasureirt is the value of cadence,
stride length or total time for the r-th measurement
made at time t (t = baseline, T24 h, T72 h) on the i-th
subject; β0 is the constant term, β1Ti is the term that
models the trend of PerformanceMeasure along the three
time points t. This model also includes an occasional-
specific random intercept for each subject b0it, that takes
into account possible correlations among the three test
repetitions on same t.
In order to evaluate the contribution of clinical scales
in addition to gait analysis parameters, to the three
models reported in Eq. 1, the scores of Gait Status Scale,
Tinetti Balance, Tinetti Gait, Tinetti, and Grading Scale
were added, and the ones relative to T24 h were
removed (Eq. 2). Proceeding likewise for Eq. 1, final fit-
ting of the regression models was carried with backward
elimination.
Equation 2: Complete linear model with mixed effects
used to determine effect of CSF during instrumented
TUG and 18mW using spatio-temporal gait parameters
and clinical scales scores as regressors
PerformanceMeasureirt ¼ β0 þ β1Ti þ agei þ BMIi
þ diagnosisi
þ doubleSupportDurationirt
þ PCIirt þ turningStepsirt
þ sitToStandirt
þ standToSitirt
þ walkTimeirt
þ Gait Status Scaleit
þ Tinetti Balanceit
þ Tinetti Gaitit þ Tinettiit
þ Grading Scaleit þ b0it
þ εirt ≡ μit þ b0it þ εirt
Subscripts apply as in Eq. 1.
Finally, with the aim of analyzing the behavior of clinical
rating scales alone with respect to responsive variables, a
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linear mixed model was realized using scores of clinical
scales as the only predictors (Eq. 3).
Equation 3: Complete linear model with mixed effects
used to determine effect of CSF-TT using clinical scales
scores as regressors
PerformanceMeasureirt ¼ β0 þ β1Ti þ agei þ BMIi
þ diagnosisi
þ Gait Status Scaleit
þ Tinetti Balanceit
þ Tinetti Gaitit þ Tinettiit
þ Grading Scaleit
þ εirt ≡ μit þ εirt
Subscripts apply as in Eq. 1.
The contribution of each term on the right side of the
three former equations, in the attempt to explain the vari-
ance of the three responsive variables on the left side, has
been processed by the linear mixed models and eliminated
just in case the deterioration to the fit of the reduced model
was statistically insignificant.
Results
Participant flow
Among the 151 persons with suspicion of iNPH referred
at IRCCS Institute, 76 patients received a diagnosis of
iNPH. Fifty-six were p-iNPH forms whereas 20 were v-
iNPH. Table 1 reports demographical, clinical and
neurological characteristics of the iNPH sample and the
number of motor test acquisitions.
Patients unable to walk at baseline were excluded
from the following analyses. Final dataset consisted of
45 p-iNPH (mean age (standard deviation): 73.9 (5.0)
years; BMI: 28.1 (3.8) kg/m2) and 20 v-iNPH (mean age
(standard deviation): 76.7 (3.1) years; BMI: 25.1 (4.0)
kg/m2). These groups differed significantly in terms of
mean age (t-test, p < 0.01) and mean BMI (t-test, p <
0.01); age and BMI were therefore included in the
Table 1 Baseline demographic, clinical and neurological characteristics of subjects and number of motor test acquisitions
Total p-iNPH v-iNPH
Demographic
Subjects 76 56 20
Males (%) 43 (57) 31 (55) 12 (60)
Mean age at disease onset (st. Dev) 72 (5.7) 71 (6.2) 73 (3.3)
Mean age at evaluation (st. Dev) 75 (4.7) 74 (5.1) 77 (3.0)
Disease duration < 12 months 21 18 3
Disease duration > 12 months 55 38 17
BMI, [kg/m2] (st. Dev) 27 (4.1) 28 (3.9) 25 (4.1)
Clinical profile
Symptoms at first evaluation
1, subjects (%) 6 (8) 6 (11) 0
2, subjects (%) 18 (24) 13 (23) 5 (25)
3, subjects (%) 52 (68) 37 (66) 15 (75)
gait disorders, subjects (%) 76 (100) 56 (100) 20 (100)
urinary dysfunctions, subjects (%) 63 (83) 47 (84) 16 (80)
cognitive impairments, subjects (%) 58 (76) 39 (70) 19 (95)
Number of falls in the last 6 months
0, (%) 17 (22) 12 (21) 5 (25)
1, (%) 15 (20) 12 (21) 3 (15)
≥ 2, (%) 44 (58) 32 (57) 12 (60)
Mean ARWMC (st. Dev) 7.2 (4.6) 5.0 (2.7) 13.7 (2.3)
Motor tests
TUG total trials acquired 585 405 180
TUG discarded (incomplete acquisitions) 31 (5%) 22 (5%) 9 (5%)
18mW total trials acquired 405 300 135
18mW discarded (incomplete acquisitions) 32 (8%) 21 (7%) 11 (8%)
BMI Body mass index; ARWMC Age-Related White Matters Changes
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regression model to study their possible differential
effect on performance (Eq. 1).
Instrumental gait analysis of TUG and 18mW
A total of 585 trials were acquired using mGAIT. Few of
these trials were not completed either because patients
lost focus on the task to accomplish or because they
were too demanding from the physical point of view and
were excluded from following analysis (Table 1). Three
hundred eighty-three TUG and 279 18 mW trials for p-
iNPH patients plus 171 TUG and 124 18 mW trials for
v-iNPH patients were finally considered for the statis-
tical analysis. Figure 1 shows a typical IMUs recording
for TUG and 18 mW relative to a p-iNPH subject
acquired at T24 h. In particular, heel strikes and foot offs
are superimposed on top of shoes medio-lateral angular
velocities; as well starts and ends of sit-to-stand and
stand-to-sit phases on top of trunk antero-posterior
acceleration. Figure 2 shows in a radar chart the pro-
gression, for the two groups and the two motor tests, of
the median cadence, stride length, total time, total steps,
double support, and gait speed along the three time
points (baseline, T24 h and T72 h) using normative data
as reference. Figure 3 shows more in detail via box plots
all values obtained for gait speed across the two groups,
the three time points, and the two motor tests.
Table 2 reports the final statistical model, after regres-
sor selection via backward elimination. Comparing re-
sults at baseline vs. T24 h and T72 h, the TUG disclosed
a statistically significant improvement for cadence both
at T24 h (p < 0.01) and T72 h (p < 0.001), for total time
just at T72 h (p < 0.05), whereas stride length modifica-
tions were statistically not relevant. The 18 mW revealed
both for stride length and cadence an improvement at
T24 h (p < 0.05 and p < 0.001, respectively) and at T72 h
(p < 0.05 in both cases), however total time never
showed the time effect as significant. Belonging to p-
iNPH or v-iNPH did not provide a relevant contribution
to explain any of the outcome measures. However,
values obtained disclosed on average a decreased per-
formance of v-iNPH subjects compared to p-iNPH sub-
jects, with a trend towards significance in 18mW where
v-iNPH showed on average an increase of 2 s on test
total time.
The change in stride length, cadence and total time
measured with TUG, other than pre vs. post compari-
son, was mostly predicted by the reduction of the dur-
ation of double support, the number of turning steps,
and the value of PCI. In particular, double support dur-
ation showed a high statistical significance (p < 0.001)
across the two motor tests, where to its unitary incre-
ment corresponded an average decrease of stride length
(of 1.6 cm in TUG and 1.9 cm in 18mW), and cadence
(of 0.3 in TUG and 0.4 strides/min in 18 mW) and, on
average, an increase of total time (of 0.6 s in TUG and
1.2 s in 18mW). The time to complete TUG was also
explained by duration of sit-to-stand and stand-to-sit
phases. As well, the 18 mW was predicted both by the
duration of double support and PCI.
In order to verify the homoscedasticity of random
effects, the Levene test was performed on model resid-
uals and reported in Table 3. In particular, the variability
among subjects excluding the time effect, the variability
among time points including all subjects’ trials, and the
intersection between these latter two were considered.
The homoscedasticity of random effects is never
present (p < 0.003) when the inter-subject variability
alone is considered (Table 3), showing how patients per-
formances differ considerably among themselves and
along time points. On the contrary, during TUG along
time homoscedasticity is always present (p > 0.3) show-
ing how overall variability at baseline, T24 h and T72 h
did not differ. Also on 18mW homoscedasticity is
present along time for cadence but not for stride length
and total time, testifying how from baseline to T72 h the
variability changed. Finally, considering the time-subject
interaction the homoscedasticity is always present both
for TUG and 18mW except for the outcome total time
in TUG (p < 0.05).
Clinical scales
The clinical scales were fulfilled on 56 p-INPH and 20
v-iNPH patients. However, in few cases patients were
not able to perform clinical test tasks; Table 4 reports
mean, standard deviation and number of patients able to
execute the tests. At baseline, v-iNPH patients presented
on average higher mean values for Gait Status Scale
when compared to p-iNPH, 6.4 vs. 5.5 respectively, but
without reaching statistical significance. Tinetti Balance,
Tinetti gait, Tinetti, and Grading Scale also did not show
relevant differences between groups (Table 4).
Table 5 reports final fitting of the regression models of
the contribution of clinical scales in addition to gait ana-
lysis parameters as specified in Eq. 2.
Considering the results of TUG, reported in Table 5,
compared to the ones relative to the model of Eq. 1, PCI
remained significant just in the prediction of total time.
Both Tinetti Gait and Gait Status Scale were not elimi-
nated from the model fitting of stride length and in cor-
respondence to their unitary increment, stride length
increased respectively of 1.2 cm and decreased of 1 cm,
on average. Grading Scale, as well, was considered as an
explanatory variable in prediction of cadence with an
average increase of 0.6 strides/min per its unitary incre-
ment. Finally, Tinetti Balance was the only clinical scale
remaining in the prediction of total time, providing a
contribution more relevant with respect to sit-to-stand
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Fig. 1 Typical IMUs recording for a) TUG and b) 18 mW of a p-iNPH subject acquired at T24 h. Heel strikes (downward triangles) and foot offs
(upward triangles) are superimposed on top of shoes medio-lateral angular velocities (right in green and left in red); as well, starts (rightward
triangles) and ends (leftward triangles) of sit-to-stand and stand-to-sit phases are shown (when present) on the antero-posterior inclination (in
blue) recorded from the sensor placed on lower back
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time and turning steps. TUG total time decreased on
average of 0.9 s per single increment of Tinetti Balance.
When considering cadence in 18mW results (Table 5),
all scales gave statistically insignificant deterioration to the
fit of the reduced model and were therefore eliminated.
Tinetti gait was the only scale not eliminated for total
time, which was reduced of 1.4 s, on average, per its uni-
tary increment. Tinetti Gait, Grading Scale and Tinetti
Balance gave their relevant contribution to explain stride
length variability. In correspondence of a unitary incre-
ment of Tinetti Gait, Grading Scale and Tinetti Balance,
stride length respectively increased of 2.8 cm and de-
creased of 1.6 cm and 2 cm, on average. As in previous
model, the homoscedasticity of random effects was veri-
fied by means of the Levene test on model residuals
(Table 6).
Same considerations as for the model described by
Eq. 1 can be applied here. In the interaction time-
subject the homoscedasticity is always present both
for TUG and 18 mW except for the outcome total
time in TUG (p < 0.001).
The contribution of clinical rating scales alone to
explain responsive variables, as detailed in Eq. 3, is
reported in Table 7 During TUG stride length was pre-
dicted with statistical significance by Gait Status Scale,
with a unitary increase of this scale producing a stride
1.7 cm shorter, on average. For 18 mW, other than Gait
Status Scale shortening on average the stride of 2.3 cm
per unitary increment, Tinetti Gait was also not elimi-
nated producing a stride 5.9 cm longer per unitary incre-
ment, on average. Grading scale significantly contributed
to explain total time and cadence variability during
TUG, with its unitary increment determining respect-
ively an increase of 1.8 s and a decrease of 0.9 strides/
min, on average. Time effect resulted also statistically
relevant for cadence both during TUG and 18mW
(Table 7).
Discussion
This observational cohort study is one of the largest
monocentric studies carried out so far on idiopathic nor-
mal pressure hydrocephalus, a complex and often mis-
diagnosed syndrome. In this study, out of 151 patients
with suspected hydrocephalus from brain imaging and at
least one symptom of the classical triad, 76 were
A
B
C
D
Fig. 2 Radar plots of the progression of median values of cadence,
stride length, total time, total steps, double support, and gait speed
for a p-iNPH on TUG, b v-iNPH on TUG, c p-iNPH on 18mW and d
v-iNPH on 18 mW from baseline to T72 h. Distances are normalized
with respect to baseline (blue lines) and normative values (green
dot lines) derived for TUG from [18, 38]; for 18 mW from [33]. Red
plots refer to the p-iNPH group, yellow plots to the v-iNPH group.
Cadence is expressed in steps per minute
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AB
Fig. 3 Box plot of all values obtained for responsive variables cadence, stride length and total time along the three time points baseline, T24 h and T72 h, and
the two motor tests a TUG, and b 18mW. Red boxes refer to the p-iNPH group (numbers in red report the median value), yellow boxes to the v-iNPH group
(numbers in yellow report the median value). A single median value for the three repetitions was considered. Numbers in black represent the number of
patients who successfully completed the tests
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diagnosed as iNPH by a clinical multidisciplinary team
following a standardized protocol.
Motor performance was measured using inertial sen-
sors which allowed to instrument the TUG and the 18
mW tests without affecting the clinical routine. More so,
IMUs allowed to measure gait parameters such as the
duration of the double support phase and the PCI that
are directly related to typical disturbances of iNPH as
the presence of magnetic gait and of apraxia. Cadence,
stride length and total time, being three main
Table 2 Results of the three linear models with mixed effects built on the responsive variables stride length, cadence and total time
(Eq. 1) from gait analysis data of TUG and 18 mW at baseline, T24 h and T72 h
TUG 18mW
Value p-value Value p-value
Stride length [cm] (Intercept) 140.3 0.000 (Intercept) 157.2 0.000
T24 h −0.1 0.878 T24 h 1.8 0.023 *
T72 h 1.4 0.113 T72 h 3.1 0.027 *
v-iNPH vs p-iNPH −3.5 0.237 v-iNPH vs p-iNPH −5.5 0.164
double support duration −1.6 0.000 *** double support duration −1.9 0.000 ***
PCI −0.02 0.024 * PCI −0.1 0.001 ***
n. turning steps −2.0 0.000 ***
Cadence [strides/min] (Intercept) 58.8 0.000 (Intercept) 63.3 0.000
T24 h 1.8 0.009 ** T24 h 1.5 0.000 ***
T72 h 2.4 0.001 *** T72 h 1.7 0.018 *
v-iNPH vs p-iNPH −0.6 0.774 v-iNPH vs p-iNPH −0.7 0.654
double support duration −0.3 0.000 *** double support duration −0.4 0.000 ***
PCI −0.01 0.006 ** PCI 0.1 0.000 ***
n. turning steps 0.4 0.015 *
Total time [s] (Intercept) −10.5 0.000 (Intercept) −10.8 0.001
T24 h −1.8 0.190 T24 h −2.9 0.108
T72 h −2.8 0.031 * T72 h −2.7 0.160
v-iNPH vs p-iNPH 0.4 0.677 v-iNPH vs p-iNPH 2.0 0.137
double support duration 0.6 0.000 *** double support duration 1.2 0.000 ***
PCI 0.1 0.000 *** PCI 0.2 0.000 ***
n. turning steps 1.7 0.000 ***
Sit-down duration 0.5 0.000 ***
Stand-up duration 0.5 0.005 **
T24 h and T72 h post 24 and 72 h the CSF tap test;
v-iNPH vs p-iNPH pure iNPH group vs iNPH with vascular encephalopathy comorbidity group;
PCI phase coordination index;
Values of stride length are expressed in cm, of cadence in strides/min, of total time in s;
Significance codes: ‘***’ p < 0.001, ‘**’ p < 0.01, ‘*’ p < 0.05
Table 3 Levene’s Test for homogeneity of variance on residuals of statistical model of Eq. 1
TUG 18mW
Stride length
p-value
Cadence
p-value
Total time
p-value
Stride length
p-value
Cadence
p-value
Total time
p-value
i 0.001*** 0.000*** 0.000*** 0.002** 0.003** 0.001***
t 0.913 0.374 0.835 0.016* 0.536 0.049*
i*t 0.999 0.400 0.017* 0.993 0.829 0.787
i variability among subjects;
t variability among time points baseline, T24 h and T72 h;
i*t: variability among subjects and time points;
Significance codes: ‘***’ p < 0.001, ‘**’ p < 0.01, ‘*’ p < 0.05
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complimentary components of locomotion, were se-
lected as response variables of statistical models imple-
mented to assess modifications caused by CSF-TT,
hence to establish and quantify its effect on symptoms
improvement. The choice to use a 18mW allowed the
stress the locomotor abilities of patients, but the use of
the more standard 10 mW would have allowed a broader
opportunity of comparisons with the literature and in
future studies might be preferred.
Comparing gait analysis results obtained in the TUG
test at baseline and post-CSF-TT, on average, as showed
in Fig. 3a, patients increased their cadence and reduced
the time required to complete the test (Table 2). Con-
versely, stride length did not change, probably due to the
Table 4 Mean scores of clinical scales
p-iNPH v-iNPH
Mean scores Baseline T72 h Baseline T72 h
Gait Status Scale (st. Dev) [subjects] 5.5 (3.8) [54] 4.3 (3.5) [53] 6.4 (3.3) [19] 4.3 (2.7) [18]
Tinetti Balance 12.0 (3.7) [54] 13.8 (2.5) [52] 11.7 (2.9) [19] 13.1 (2.6) [18]
Tinetti Gait 7.0 (3.4) [54] 8.8 (2.6) [52] 6.8 (3.0) [19] 8.6 (2.5) [18]
Tinetti 18.9 (6.6) [54] 22.4 (4.7) [52] 18.6 (5.4) [19] 21.7 (4.6) [18]
Grading Scale 5.9 (2.4) [56] 4.5 (2.1) [53] 5.9 (2.3) [19] 5.2 (2.7) [18]
st. Dev standard deviation;
[subjects]: number of subjects able to execute the tasks of the clinical scale;
T72 h post 72 h the CSF tap test;
p-iNPH pure iNPH group;
v-iNPH iNPH with vascular encephalopathy comorbidity group
Table 5 Results of the statistical analysis on the outcome measures stride length, cadence and total time considering as predictors
both the instrumental gait analysis parameters and the scores of clinical scales (model defined in Eq. 2)
TUG 18 mW
Value p-value Value p-value
Stride length [cm] (Intercept) 135.4 0.000 (Intercept) 164.3 0.000
T72 h −1.9 0.064 T72 h 2.9 0.071
v-iNPH vs p-iNPH −2.0 0.414 v-iNPH vs p-iNPH −3.1 0.307
double support duration −1.6 0.000 *** double support duration −1.9 0.000 ***
n. turning steps −2.9 0.000 *** PCI −0.1 0.035 *
Tinetti Gait 1.2 0.004 ** Tinetti Gait 2.8 0.000 ***
Gait Status Scale −1.0 0.010 ** Gait Status Scale −2.0 0.004 *
Tinetti Balance −1.6 0.043 *
Cadence [strides/min] (Intercept) 59.5 0.000 (Intercept) 63.4 0.000
T72 h 3.0 0.000*** T72 h 1.6 0.070
v-iNPH vs p-iNPH −0.9 0.670 v-iNPH vs p-iNPH 0.1 0.944
double support duration −0.4 0.000 *** double support duration −0.4 0.000 ***
n. turning steps 0.7 0.002 ** PCI 0.1 0.001 ***
Gait Status Scale 0.6 0.004 **
Total time [s] (Intercept) 2.5 0.549 (Intercept) 13.9 0.032
T72 h −1.6 0.156 T72 h −1.7 0.446
v-iNPH vs p-iNPH 0.3 0.757 v-iNPH vs p-iNPH 1.2 0.482
double support duration 0.7 0.000 *** double support duration 0.8 0.000 ***
PCI 0.03 0.000 *** PCI 0.2 0.000 ***
Sit-down duration 0.6 0.000 *** Tinetti Gait −1.4 0.001 ***
Tinetti Balance −0.9 0.000 ***
T72 h post 72 h the CSF tap test;
v-iNPH vs p-iNPH pure iNPH group vs iNPH with vascular encephalopathy comorbidity group
PCI phase coordination index
Significance codes: ‘***’ p < 0.001, ‘**’ p < 0.01, ‘*’ p < 0.05
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nature of TUG that limits free walking to just 3 m. On
the other hand, in the 18 mW test stride length and
cadence significantly improved, whereas the change in
total time, even showing a reduction of more than 2 s on
average (Fig. 3b, Table 2), did not reach statistical sig-
nificance. This latter result might be partially explained
by the fact that at T72 h just 15 patients performed the
18mW causing a reduced statistical power compared to
TUG. More so, this might suggest that the performance
of iNPH patients is subject to modifications not neces-
sarily involving gross motor skills, but aspects related to
the quality of motor control such as the onset of apraxia.
In line with this interpretation, double support duration
and PCI were the two regressors most influent for
explaining total time revealing how moving from base-
line to T72 h patients exhibited a gait less magnetic and
apraxic, and more coordinated and fluent.
Considering clinical scores analyzed in addition to
instrumental measures as in Eq. 2 (results in Table 5),
from baseline to T72 h patients increased their cadence
significantly in TUG. As well, concerning clinical scores
analyzed by themselves as in Eq. 3 (results Table 7), the
cadence is increased both in TUG and 18 mW. Time
effect in the explanation of the variability of performance
Table 6 Levene’s Test for homogeneity of variance on residuals of statistical model of Eq. 2
TUG 18mW
Stride Length Cadence Total time Stride Length Cadence Total time
i 0.000*** 0.000*** 0.000*** 0.344 0.341 0.141
t 0.847 0.592 0.538 0.008** 0.495 0.013*
i*t 0.989 0.146 0.001*** 0.882 0.771 0.733
i i-th subject
t time point: baseline, T24 h or T72 h
Significance codes: ‘***’ p < 0.001, ‘**’ p < 0.01, ‘*’ p < 0.05
Table 7 Results of the statistical analysis on the outcome measures stride length, cadence and total time considering the scores of
clinical scales as the only predictors (model defined in Eq. 3)
TUG 18 mW
Value p-value Value p-value
Stride length [cm] (Intercept) 46.9 0.000 (Intercept) 85.6 0.000
T72 h −2.3 0.206 T72 h 4.0 0.130
Tinetti Gait 2.4 0.209 Tinetti Gait 5.9 0.002**
Tinetti Balance 1.0 0.583 Tinetti Balance −1.6 0.392
Tinetti 0.2 0.902 Tinetti −0.4 0.808
Gait Status Scale −1.7 0.013* Gait Status Scale −2.3 0.022*
Grading Scale −1.4 0.060 Grading Scale −0.7 0.471
Cadence [strides/min] (Intercept) 51.7 0.000 (Intercept) 61.0 0.000
T72 h 2.8 0.002** T72 h 2.5 0.023*
Tinetti Gait −0.3 0.733 Tinetti Gait −0.2 0.838
Tinetti Balance 0.3 0.702 Tinetti Balance −0.2 0.825
Tinetti −0.1 0.883 Tinetti −0.1 0.845
Gait Status Scale 0.4 0.231 Gait Status Scale −0.5 0.247
Grading Scale −0.9 0.021* Grading Scale −0.4 0.398
Total time [s] (Intercept) 30.0 0.000 (Intercept) 38.7 0.006
T72 h −1.6 0.248 T72 h −2.7 0.338
Tinetti Gait 0.01 0.988 Tinetti Gait −2.2 0.096
Tinetti Balance −0.6 0.482 Tinetti Balance 1.1 0.338
Tinetti −0.3 0.670 Tinetti −0.5 0.598
Gait Status Scale 0.5 0.156 Gait Status Scale 0.6 0.391
Grading Scale 0.8 0.013* Grading Scale 0.8 0.359
T72 h post 72 h the CSF tap test;
Significance codes: ‘**’ p < 0.01, ‘*’ p < 0.05
Ferrari et al. Journal of NeuroEngineering and Rehabilitation            (2020) 17:7 Page 12 of 15
measures is therefore attenuated by the addition of clinical
scores to statistical models. When looking at the individ-
ual contribution of each scale, there was not a single scale
fitting well in all statistical models. Tinetti Gait and Gait
Status Scale were both explanatory variables in prediction
of stride length both for TUG and 18mW in the model
including quantitative measures (Table 5), but only for 18
mW in the model with clinical scales alone (Table 7),
revealing their ability to address stride length variations
besides instrumental data. Tinetti Gait was the only scale
remaining significant in explaining the variability of total
time for 18mW (Table 5), hence showing its affinity to
gait speed during an unconstrained walk. Tinetti Balance,
along with gait analysis data, Tinetti Gait and Gait Status
Scale were significant for predicting stride length in 18
mW (Table 5). More so, Tinetti Balance was the only scale
predictive of TUG total time (Table 5), probably reflecting
its ability to address those components of motor
organization related to the pattern adopted to find and
maintain balance during the sit-to-stand and stand-to-sit
postural transfers. For TUG, in the model including
instrumental data, to a unitary increment of Gait Status
Scale, theoretically corresponding to a worsening of
patients’ motor abilities, corresponded a significant in-
crease of cadence of 0.6 steps/min as well as a 1 cm reduc-
tion of stride length, on average. These results, though
partially controversial, probably reveal the presence of
shuffling gait for patients with higher values of Gait Status
Scale. In other words, with the increase of values of Gait
Status Scale the performance deteriorates in terms of
reduced stride length and, counterintuitively, increased
cadence, which clinically can be associated to the presence
of a shuffling gait.
Tinetti Gait, Tinetti Balance and Gait Status Scale in
TUG provided a contribution more relevant with respect
to stand-up time and turning steps in total time, and to
PCI in stride length and cadence. This result can be
probably ascribed to their capability of assessing a broad
spectrum of top-down components of the motor reper-
toire necessary to execute the TUG. On the contrary,
Tinetti global score and Grading Scale when analyzed
with instrumental data were never selected for model fit-
ting, revealing their inability to unveil undisclosed as-
pects of performance. Overall, the fact that some clinical
scales in the statistical model of Eq. 2 provided a contri-
bution more relevant with respect to gait analysis
parameters also suggests that other instrumental data,
obtained from inertial sensors or other devices, might be
considered in order to fully describe pre vs post-CSF-TT
modifications of motor performance just in terms of
objective data.
Grading Scale on the other hand, in the model with
clinical scales alone, was the only scale found significant
for cadence and total time in TUG, demonstrating its
ability to explain the majority of the variability of these
two outcome measures to the detriment of other clinical
scales.
When analysing the variance of statistical model resid-
uals relative to the interaction between time and sub-
jects, the homoscedasticity is always present except for
the total time in TUG (Table 3 and Table 6). This latter
finding possibly indicates that a factor relevant for the
determination of the parameter total time has not been
taken into account into the statistical model. Based on
clinical observations, this factor might have been the
cognitive ability to correctly implement the test without
hesitations, that was frequently compromised at baseline
but often recovered at T72 h. Indeed, patients at baseline
sometimes got lost during test execution, for example
continuing to walk straight instead of turning and
returning to the chair. In these cases, the TUG was dis-
closing not only the locomotor abilities but also the cog-
nitive functioning of patients. By inserting the scores of
a scale such as the Mini Mental State Examination [39]
in the statistical model of total time as a fixed effect,
could effectively account for the presence and severity of
cognitive impairment and its role in the variation of the
motor performance. Further research aimed at confirm-
ing this hypothesis should be carried out.
v-iNPH patients showed on average a reduced per-
formance compared to p-iNPH in all the different obser-
vations but without reaching the statistical significance.
Contrary to authors expectations, important vascular en-
cephalopathy present in persons with v-iNPH was not a
factor causing a different post-CSF-TT course. This
result might be partially explained by the fact that the
high individual variability modeled with the random
intercept captured only part of the variability ascribed to
the two iNPH groups. On the other hand, this result
suggests that vascular encephalopathy is not a comorbid-
ity limiting the improvement of gait following CSF-TT.
In the present study, the ARWMC was dichotomized in
order to ease the clinical interpretation of the results.
However, including this variable into the statistical
models themselves as fixed effect might increase the
variance explained and turn out to be a significant pre-
dictor of the responsive variables.
When comparing different post-CSF-TT assessment
times, the better performances were recorded 72 h after
the CSF-TT. This finding is clearly visible in the radar
plots of Fig. 2 where the hexagon relative to median
values of spatio-temporal gait parameters recorder at
T72 h is always including, meaning better performance,
the one relative to T24 h. These results are in agreement
with those reported by Schniepp et al. but in contrast to
other studies [10, 22], and in particular with the work of
Virhammar et al. that proposed to make the post-CSF-
TT evaluation any time within the first 24 h [12]. These
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findings also suggest that previous studies investigating
motor improvements in early time points could have
underestimated the CSF-TT response.
Conclusions
Inertial sensors used to instrument motor tests on iNPH
patients allowed to assess changes on performances due to
CSF-TT without affecting the clinical routine and unveiling
aspects of locomotion and postural transfers not accessible
simply using clinical observations or clinical scales. On
average, patients improved the performance from baseline
to post-CSF-TT particularly increasing cadence in 18mW
and TUG and stride length in 18mW. More so, the use of
data from inertial sensors and mixed effects models allowed
to show how the improvement was significant especially in
those gait parameters reflecting a decrease in apraxia such
as the reduction of double support duration and the in-
crease of coordination.
Tinetti Gait, Tinetti Balance and Gait Status Scale
were the scales able, better than others, to address part
of the variability of response variables not explained by
sensor data. Additionally, these scales in TUG provided
a contribution more relevant with respect to stand-up
time and turning steps in total time, and to PCI in stride
length and cadence, showing the capability to assess
components of the motor repertoire not appropriately
addressed by gait parameters. On the other hand, when
considering clinical scales alone, Grading Scale was the
scale with highest affinity in explaining TUG total time
and cadence.
v-iNPH patients compared to p-iNPH showed worst
performances in all evaluations but without reaching
statistical significance. This comorbidity was not a factor
causing a different post-CSF-TT course by limiting gait
improvement.
Maximal increase in outcome measures occurred the
third day after the CSF-TT, revealing how this interval
should be the considered as the best spot to assess CSF-
TT efficacy in iNPH.
In conclusion, the results obtained in this study sug-
gest that it is possible to improve the assessment of ef-
fectiveness of the CSF-TT by including the instrumented
evaluation of spatio-temporal gait parameters and setting
the time for post-CSF-TT evaluation at 72 h.
Abbreviations
18 mW: 10 m walking test (10 mW) extended to the distance of 18 m;
ARWMC: Age-Related White Matters Changes scale; CSF: Cerebrospinal fluid;
IMUs: Inertial measurement units; iNPH: Idiopathic normal pressure
hydrocephalus.; PCI: Phase coordination index; p-iNPH: Pure iNPH group;
TT: Tap-test; TUG: Timed-up and go test; v-iNPH: iNPH with vascular
encephalopathy comorbidity group
Acknowledgements
The authors would like to thank Dr. Stefania Magnoni and Dr. Silvia Muscari for
or their help in collecting and analyzing the data during their Master thesis.
Suppliers
a. mHealth Technologies.
b. MATLAB; MathWorks.
c. R; https://www.r-project.org/
Authors’ contributions
Conceptualization: GP, PC and LC. Data Curation: SC and GG. Data
Acquisition: DM and GG. Data Interpretation: DM, GG, GP, FO, LAR, PM, SC,
AF and LC. Data Processing: AF. Statistical Analysis: LA. Original Draft
Preparation: AF. Review & Editing: LC, AF. All authors read and approved the
final manuscript.
Funding
This research was conducted with internal institutional funds of University of
Bologna and the IRCCS Istituto delle Scienze Neurologiche of Bologna.
Availability of data and materials
Please contact corresponding author.
Ethics approval and consent to participate
Subjects provided written informed consent prior to participation to the
study according to the declaration of Helsinki. Ethical approval was provided
by the ethics committee of the health service of Bologna reference CE 14131
23/02/2015, and was conducted in agreement with principles of good
clinical practice.
Consent for publication
All participants gave written informed consent.
Competing interests
Two of the authors are founders of mHealth Technologies s.r.l., the company
that manufactures and sells systems that are similar to the one used in this
study.
Author details
1Health Sciences and Technologies - Interdepartmental Center for Industrial
Research (CIRI-SDV), Alma Mater Studiorum - University of Bologna, Bologna,
Italy. 2Unit of Rehabilitation Medicine, IRCCS Istituto delle Scienze
Neurologiche di Bologna, Bologna, Italy. 3Unit of Neurology, IRCCS Istituto
delle Scienze Neurologiche di Bologna, Bologna, Italy. 4Department of
Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna,
Bologna, Italy. 5Unit of Neurosurgery, IRCCS Istituto delle Scienze
Neurologiche di Bologna, Bologna, Italy. 6Unit of Neuroradiology, IRCCS
Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. 7Department
of Statistical Sciences, University of Bologna, Bologna, Italy. 8Department of
Electrical, Electronic, and Information Engineering “Guglielmo Marconi” (DEI),
University of Bologna, Bologna, Italy.
Received: 17 April 2019 Accepted: 22 December 2019
References
1. Hakim S, Adams RD. The special clinical problem of symptomatic
hydrocephalus with normal cerebrospinal fluid pressure. Observations on
cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2:307–27.
2. Gallia GL, Rigamonti D, Williams MA. The diagnosis and treatment of
idiopathic normal pressure hydrocephalus. Nat Clin Pract Neurol. 2006;2(7):
375-81.
3. Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD.
Systematic review of the outcome of shunt surgery in idiopathic normal-
pressure hydrocephalus. Acta Neurochir (Wien). 2013;155(10):1977-80.
4. Relktin N, Marmarou A, Klinge P, Bergsneider M, Black PML. INPH guidelines,
part II: diagnosing idio-pathic normal-pressure hydrocephalus. Neurosurgery.
2005;57:4–16.
5. Marmarou A, Bergsneider M, Relkin N, Klinge P, Black PM. Development of
Guidelines for Idiopathic Normal-pressure Hydrocephalus: Introduction.
Neurosurgery. 2005;57:S2–1-S2–3.
6. Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, et al. Guidelines
for management of idiopathic normal pressure hydrocephalus: second
edition. Neurol Med Chir (Tokyo). 2012;52:775–809.
Ferrari et al. Journal of NeuroEngineering and Rehabilitation            (2020) 17:7 Page 14 of 15
7. Agostini V, Lanotte M, Carlone M, Campagnoli M, Azzolin I, Scarafia R,
et al. Instrumented gait analysis for an objective pre−/postassessment
of tap test in normal pressure hydrocephalus. Arch Phys Med Rehabil.
2015;96:1235–41.
8. Liston R, Mickelborough J, Bene J, Tallis R. A new classification of higher
level gait disorders in patients with cerebral multi-infarct states. Age Ageing.
2003;32:252–8.
9. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of
supplemental prognostic tests for the preoperative assessment of
idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57:S17–28
discussion ii-v.
10. Mihalj M, Dolić K, Kolić K, Ledenko V. CSF tap test - obsolete or appropriate
test for predicting shunt responsiveness? A systemic review. J Neurol Sci.
2016;362:78–84.
11. Ravdin LD, Katzen HL, Jackson AE, Tsakanikas D, Assuras S, Relkin NR.
Features of gait most responsive to tap test in normal pressure
hydrocephalus. Clin Neurol Neurosurg. 2008;110:455–61.
12. Virhammar J, Cesarini KG, Laurell K. The CSF tap test in normal pressure
hydrocephalus: evaluation time, reliability and the influence of pain. Eur J
Neurol. 2012;19:271–6.
13. Kubo Y, Kazui H, Yoshida T, Kito Y, Kimura N, Tokunaga H, et al. Validation of
grading scale for evaluating symptoms of idiopathic normal-pressure
hydrocephalus. Dement Geriatr Cogn Disord. 2007;25:37–45.
14. Muro-de-la-Herran A, García-Zapirain B, Méndez-Zorrilla A. Gait analysis
methods: an overview of wearable and non-wearable systems, highlighting
clinical applications. Sensors (Switzerland). 2014;14:3362–94.
15. Ferrari A, Ginis P, Hardegger M, Casamassima F, Rocchi L, Chiari L. A Mobile
Kalman-filter based solution for the real-time estimation of Spatio-temporal
gait parameters. IEEE Trans Neural Syst Rehabil Eng. 2016;24:764–73.
16. Yang F, Hickman T-T, Tinl M, Iracheta C, Chen G, Flynn P, et al.
Quantitative evaluation of changes in gait after extended cerebrospinal
fluid drainage for normal pressure hydrocephalus. J Clin Neurosci. 2016;
28:31–7.
17. Stolze H, Kuhtz-Buschbeck JP, Drücke H, Jöhnk K, Diercks C, Palmié S, et al.
Gait analysis in idiopathic normal pressure hydrocephalus - which parameters
respond to the CSF tap test? Clin Neurophysiol. 2000;111:1678–86.
18. Panciani PP, Migliorati K, Muratori A, Gelmini M, Padovani A, Fontanella
M. Computerized gait analysis with inertial sensor in the management
of idiopathic normal pressure hydrocephalus. Eur J Phys Rehabil Med.
2018;54:724–9.
19. Bovonsunthonchai S, Witthiwej T, Ngamsombat C, Sathornsumetee S,
Vachalathiti R, Muangpaisan W, et al. Effect of spinal tap test on the
performance of sit-to-stand, walking, and turning in patients with idiopathic
normal pressure hydrocephalus. Nagoya J Med Sci. 2018;80:53–60.
20. Allali G, Laidet M, Armand S, Momjian S, Marques B, Saj A, et al. A combined
cognitive and gait quantification to identify normal pressure
hydrocephalus from its mimics: the Geneva’s protocol. Clin Neurol
Neurosurg. 2017;160:5–11.
21. Tinetti ME, Franklin Williams T, Mayewski R. Fall risk index for elderly patients
based on number of chronic disabilities. Am J Med. 1986;80:429–34.
22. Gallagher R, Marquez J, Osmotherly P. Gait and balance measures can
identify change from a cerebrospinal fluid tap test in idiopathic Normal
pressure hydrocephalus. Arch Phys Med Rehabil. 2018;99:2244–50.
23. Allali G, Laidet M, Beauchet O, Herrmann FR, Assal F, Armand S. Dual-task
related gait changes after CSF tapping: a new way to identify idiopathic
normal pressure hydrocephalus. J Neuroeng Rehabil. 2013;10:1–6.
24. Armand S, Allet L, Landis T, Beauchet O, Assal F, Allali G. Interest of dual-
task-related gait changes in idiopathic normal pressure hydrocephalus. Eur J
Neurol. 2011;18:1081–4.
25. Schniepp R, Trabold R, Romagna A, Akrami F, Hesselbarth K, Wuehr M,
et al. Walking assessment after lumbar puncture in normal-pressure
hydrocephalus: a delayed improvement over 3 days. J Neurosurg. 2017;
126:148–57.
26. Giannini G, Palandri G, Ferrari A, Oppi F, Milletti D, Albini-Riccioli L, et al. A
prospective evaluation of clinical and instrumental features before and after
ventriculo-peritoneal shunt in patients with idiopathic Normal pressure
hydrocephalus: the Bologna PRO-hydro study. Parkinsonism Relat Disord
England. 2019;66:117–24.
27. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A
new rating scale for age-related white matter changes. Stroke. 2001;32:
1318–22.
28. Mendes GAS, de Oliveira MF, Pinto FCG. The timed up and go test as a
diagnostic criterion in Normal pressure hydrocephalus. World Neurosurg
Elsevier Inc. 2017;105:456–61.
29. Kahlon B, Sundbärg G, Rehncrona S. Comparison between the lumbar
infusion and CSF tap tests to predict outcome after shunt surgery in
suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry.
2002;73:721–6.
30. Casamassima F, Ferrari A, Milosevic B, Ginis P, Farella E, Rocchi L. A wearable
system for gait training in subjects with Parkinson’s disease. Sensors (Basel).
2014;14:6229–46.
31. Plotnik M, Giladi N, Hausdorff JM. A new measure for quantifying the
bilateral coordination of human gait: effects of aging and Parkinson’s
disease. Exp Brain Res. 2007;181:561–70.
32. Palmerini L, Mellone S, Avanzolini G, Valzania F, Chiari L. Quantification of
motor impairment in Parkinson’s disease using an instrumented timed up
and go test. IEEE Trans Neural Syst Rehabil Eng. 2013;21:664–73.
33. Hollman JH, McDade EM, Petersen RC. Normative spatiotemporal gait
parameters in older adults. Gait Posture. 2011;34:111–8.
34. Gueorguieva R, Krystal JH. Move Over ANOVA. Arch Gen Psychiatry.
2004;61:310–7.
35. Prescott RJ. Avoid being tripped up by statistics: statistical guidance for a
successful research paper. Gait Posture. 2019;72:240-9.
36. Stewart S, Pearson J, Rome K, Dalbeth N, Vandal AC. Analysis of data
collected from right and left limbs: accounting for dependence and
improving statistical efficiency in musculoskeletal research. Gait Posture.
2018;59:182–7.
37. Gałecki A, Burzykowski T. Linear Mixed-Effects Models Using R. New York:
Springer; 2013.
38. Bonnyaud C, Pradon D, Vaugier I, Vuillerme N, Bensmail D, Roche N. Timed
Up and Go test: Comparison of kinematics between patients with chronic
stroke and healthy subjects. Gait Posture. 2016;49:258–63.
39. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method
for grading the cognitive state of patients for the clinician. J Psychiatr Res.
1975;12:189–98.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Ferrari et al. Journal of NeuroEngineering and Rehabilitation            (2020) 17:7 Page 15 of 15
